It occurs when hypoxia causes tumour cells to release growth factors such as vascular endothelial growth factor (VEGF), which stimulate nearby endothelial cells (ECs) to activate appropriate growth factor receptors, e.g. VEGF-receptor-2 (VEGFR2). The gene discussed is VEGFA; the disease is neoplasm.